Urinary tract infection or Pyelonephritis
Conditions
Brief summary
The proportion of children with a recurrent UTI during 6-month follow up.
Detailed description
Number of culture-confirmed UTIs per person-years at risk (PYR), Number of hospitalization days due to UTIs, Number of days of antibiotic treatment for suspected/confirmed UTIs after the initial study entry antibiotics end, Number of days of antibiotic treatment for any reason after initial antibiotics end, Number of days the child experienced abdominal pain, Number of days the child experienced diarrhoea
Interventions
DRUGMutaflor 10^8 CFU/ml oraalisuspensio
DRUG• Alternative 1 (DF-2004 standard): Sucrose 630 mg/g
DRUGPurified Water (Aqua purificata) 370 mg/g.
• Alternative 2 (DAB standard): Sucrose (Saccharum) 640 mg/g
DRUGPurified Water (Aqua purificata) 360 mg/g.
Sponsors
Pohjois-Pohjanmaan hyvinvointialue
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of children with a recurrent UTI during 6-month follow up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of culture-confirmed UTIs per person-years at risk (PYR), Number of hospitalization days due to UTIs, Number of days of antibiotic treatment for suspected/confirmed UTIs after the initial study entry antibiotics end, Number of days of antibiotic treatment for any reason after initial antibiotics end, Number of days the child experienced abdominal pain, Number of days the child experienced diarrhoea | — |
Outcome results
None listed